“IMMUNE CHECKPOINT INHIBITORS IN SOLID TUMORS: MECHANISMS, CLINICAL EFFICACY, BIOMARKER-GUIDED PATIENT SELECTION, AND IMMUNE-RELATED ADVERSE EVENTS”. Journal of Multidisciplinary Sciences and Innovations 5, no. 03 (March 22, 2026): 1709–1714. Accessed April 16, 2026. https://ijmri.de/index.php/jmsi/article/view/6590.